TITLE

Raloxifen stimuliert Osteoprotegerin und hemmt Interleukin-6 in humanen Osteoblasten

PUB. DATE
September 2004
SOURCE
Archives of Gynecology & Obstetrics;Sep2004 Supplement 1, Vol. 270, pS79
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Raloxifen stimuliert Osteoprotegerin und hemmt Interleukin-6 in humanen Osteoblasten," by V. Viereck, L. C. Hofbauer, C. Gründker and G. Emons is presented.
ACCESSION #
21721733

 

Related Articles

  • Correction.  // Diabetes Care;Jan2013, Vol. 36 Issue 1, p183 

    A correction to the article "Reciprocal Association of Plasma IGF-1 and Interleukin-6 Levels With Cardiometabolic Risk Factors in Nondiabetic Subjects," by E. Succurro and colleagues that was published in a 2008 issue of the journal is presented.

  • IL-6 and Crohn's Disease. H. Ito // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p125 

    Interleukin-6 (IL-6) is a pleiotropic cytokine with central roles in immune regulation, inflammation, hematopoiesis, and oncogenesis. Its biological activities are shared by IL-6-family of cytokines such as leukemia inhibitory factor and oncostatin M. When IL-6 binds to IL-6R, the IL-6 / IL-6R...

  • Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach. French, J.D.; Tschumper, R.C.; Jelinek, D.F. // Leukemia (08876924);Jun2002, Vol. 16 Issue 6, p1189 

    Interleukin 6 (IL-6) has been shown to be a key growth factor for myeloma cells. To study IL-6 signal transduction in multiple myeloma (MM), we employed chimeric receptors composed of the epidermal growth factor receptor (EGFR) extracellular domain, gp130 transmembrane domain, and full-length or...

  • Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. Esposito, Pasquale; Balletta, Mario M.; Procino, Alfredo; Postiglione, Loredana; Memoli, Bruno // Lupus;Dec2009, Vol. 18 Issue 14, p1329 

    A letter to the editor is presented about the association of interleukin-6 (IL-6) release from peripheral mononuclear cells with disease activity of patients with lupus nephritis.

  • Reduced basal levels and enhanced LPS response of IL-6 mRNA in aged mice. Sharman, Kaizi; Sharman, Edward; Campbell, Arezoo; Bondy, Stephen C.; Sharman, K; Sharman, E; Campbell, A; Bondy, S C // Journals of Gerontology Series A: Biological Sciences & Medical ;Dec2001, Vol. 56 Issue 12, pB520 

    Senescence is a complex and multifactorial process that may predispose organisms to altered responses to environmental stressors. The cytokine interleukin-6 (IL-6) is expressed by a variety of cells and is one of the earliest mediators of the acute inflammatory response. In this study, the level...

  • Plasmapheresis Treatment for Bullous Pemphigoid Induces Marked Reduction of the Serum IL-6 Level Rather than the Titre of Circulating Autoantibodies. Katsuno, Masako; Sugita, Yasuyuki; Okano, Eriko; Tokura, Hirokazu; Nagatani, Tetsuo; Nakajima, Hiroshi // Acta Dermato-Venereologica;6/23/99, Vol. 79 Issue 4, p326 

    Focuses on the case of bullous pemphigoid (BP) with marked reduction of the serum interleukin-6 level after successful treatment with double-filtration plasmapheresis in Japan. Basis for the diagnosis; Factors involved in blister formation at BP; Increase of cytokines in BP patients.

  • Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein Vickers, Mark A.; Green, Fiona R.; Terry, Catherine; Mayosi, Bongani M.; Julier, Cecile; Lathrop, Mark; Ratcliffe, Peter J.; Watkins, Hugh C.; Keavney, Bernard // Cardiovascular Research;Mar2002, Vol. 53 Issue 4, p1029 

    Objective: Baseline concentrations of plasma C-reactive protein (CRP) are associated with coronary heart disease. Interleukin-6 (IL-6) regulates CRP gene expression; a promoter polymorphism (–174G/C) of the IL-6 gene has been shown to influence IL-6 transcription but the...

  • The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Kuo, Min-Liang; Chuang, Shuang-En; Lin, Ming-Tsan; Yang, Shih-Yuan // Oncogene;2/8/2001, Vol. 20 Issue 6, p677 

    Interleukin-6 (IL-6) is a pleitrophic cytokine that not only regulates growth and differentiation of many cell types, but also induces production of acute phase proteins (AAP) in hepatocytes. Our previous works have demonstrated that both PI 3-K/Akt and STAT3 pathways were concomitantly...

  • Response to Dr. Melum et al. Young Koog Cheon // American Journal of Gastroenterology;Apr2008, Vol. 103 Issue 4, p1045 

    A response by Young Koog Cheon to a letter to the editor about his article on Interleukin-6 (IL-6) is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics